Skip to Main Content

A fund launched in 2012 by the biotech venture capital firm Flagship Pioneering is on track to return its investors’ money nine times over.

That’s the eyebrow-raising return multiple for Flagship Ventures Fund IV — the highest recorded return multiple in a new STAT report that took a deep dive into returns data for more than a dozen of the country’s top biotech venture capital firms. The data includes return multiples, like Flagship’s 9x figure, for more than 15 funds, which represent both the value of its existing investments as well as the cash the fund has already returned to investors.


Most venture capitalists look for returns that ultimately double or triple their initial investments, a 2x or 3x return multiple.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!